---
run_id: halo-evidence-vs-diagnosis-validation-v9-vanilla-long-prompt-08
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v9
benchmark_version: halo-evidence-vs-diagnosis-validation-v9-v1
model_condition: vanilla_long_prompt
run_number: 8
model_name: gemma-4-31b-it-mlx
model_id: gemma-4-31b-it-mlx
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 32768
max_tokens: 1024
seed: 804
prompt_source: condition packet (vanilla_long_prompt) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 61d771e2bff7fd2e18be1d2999d0f601760656e3e69b4622989ca7bffd3aff8e
source_packet: a neutral equal-length filler plus transition, then the frozen Advisor prompt; no substrate artifact - see run-packet.md
source_packet_sha256: af424c072038c5043883f6cfe6433926f53b7b295e971021e271814b4cf97500
condition_packet_sha256: af424c072038c5043883f6cfe6433926f53b7b295e971021e271814b4cf97500
output_file: model-outputs/vanilla_long_prompt-08.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - vanilla_long_prompt (run 08)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v9-v1`, condition `vanilla_long_prompt`, run 8 of 8. Real local-model run: `gemma-4-31b-it-mlx` via lmstudio, seed 804, on the frozen condition packet.

## Output

**Recommendation:** Run the Claim File Review.

**Why:** The current signals are "entangled" and misleading. Expansion bookings are inflated by temporary pricing bundles, usage spikes are driven by managers (not the end-users), and support ticket decreases are a result of miscategorization. You cannot determine if the product provides actual value or is simply being "sold" effectively by account teams. The Claim File Review is the only option that bypasses these noisy proxies to provide ground-truth evidence on whether DraftPath's output is actually useful, accurate, or explainable to the adjuster. This is a prerequisite for any scaling decision or strategic pivot.

**Strongest Reason Against:** It is the slowest and most manual of the three validation options. Unlike the Usage Quality Sprint (automated tracking) or the Commercial Cleanroom (sales process change), a file review requires human labor and subjective analysis, which may delay the "hard data" the board expects for budget locking.

**Evidence that would change my mind:** If you discovered that the "abandonment" in the health-liability segment was not due to a lack of explainability (the "why"), but rather a technical integration failure or a specific UI bug. In that case, I would switch the recommendation to the Usage Quality Sprint to pinpoint the exact friction point in the user journey.
